# Atlantic American Corp: overview AAME · Nasdaq · CIK 8177 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/aame.md) · [Financials](/companies/aame/financials.md) · [Filings](/companies/aame/filings.md) · [Insiders](/companies/aame/insiders.md) Latest reported revenue: [$51.3m](/filings/0001140361-26-039951.md) for Q4 FY2025, three months to 2025-12-31, from the 10-K/A filed Oct 19, 2026 (XBRL us-gaap:Revenues, accession 0001140361-26-039951). ## Last eight quarters | Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [47.0](/filings/0001140361-25-018588.md) | [47.7](/filings/0001140361-25-030558.md) | [44.5](/filings/0001140361-25-042275.md) | [48.9 d](/filings/0001140361-26-039951.md) | [50.1](/filings/0001140361-25-018588.md) | [55.3](/filings/0001140361-25-030558.md) | [53.8](/filings/0001140361-25-042275.md) | [51.3 d](/filings/0001140361-26-039951.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [(4.3%)](/filings/0001140361-25-018588.md) | [(1.4%)](/filings/0001140361-25-030558.md) | [(4.5%)](/filings/0001140361-25-042275.md) | [6.7% d](/filings/0001140361-26-039951.md) | [1.6%](/filings/0001140361-25-018588.md) | [6.0%](/filings/0001140361-25-030558.md) | [1.1%](/filings/0001140361-25-042275.md) | [2.6% d](/filings/0001140361-26-039951.md) | | Diluted EPS | $ per share | [(0.10)](/filings/0001140361-25-018588.md) | [(0.04)](/filings/0001140361-25-030558.md) | [(0.10)](/filings/0001140361-25-042275.md) | not reported | [0.03](/filings/0001140361-25-018588.md) | [0.15](/filings/0001140361-25-030558.md) | [0.02](/filings/0001140361-25-042275.md) | not reported | | Free cash flow | $m | [(5.4)](/filings/0001140361-25-018588.md) | [0.4 d](/filings/0001140361-25-030558.md) | [0.1 d](/filings/0001140361-25-042275.md) | [9.5 d](/filings/0001140361-26-039951.md) | [(1.0)](/filings/0001140361-25-018588.md) | [9.1 d](/filings/0001140361-25-030558.md) | [6.6 d](/filings/0001140361-25-042275.md) | [17.7 d](/filings/0001140361-26-039951.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [200](/filings/0001140361-23-032391.md) | [188](/filings/0001140361-24-016971.md) | [187](/filings/0001140361-25-010239.md) | [188](/filings/0001140361-26-039951.md) | [210](/filings/0001140361-26-039951.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(0.7%)](/filings/0001140361-23-032391.md) | [5.1%](/filings/0001140361-24-016971.md) | [0.8%](/filings/0001140361-25-010239.md) | [(0.7%)](/filings/0001140361-26-039951.md) | [1.8%](/filings/0001140361-26-039951.md) | | Net margin | % | [2.1%](/filings/0001140361-23-032391.md) | [0.8%](/filings/0001140361-24-016971.md) | [(0.1%)](/filings/0001140361-25-010239.md) | [(0.7%)](/filings/0001140361-26-039951.md) | [2.9%](/filings/0001140361-26-039951.md) | | Diluted EPS | $ per share | [0.19](/filings/0001140361-23-032391.md) | [0.06](/filings/0001140361-24-016971.md) | [(0.03)](/filings/0001140361-25-010239.md) | [(0.09)](/filings/0001140361-26-039951.md) | [0.28](/filings/0001140361-26-039951.md) | | Free cash flow | $m | [1.0](/filings/0001140361-23-032391.md) | [6.3](/filings/0001140361-24-016971.md) | [2.5](/filings/0001140361-25-010239.md) | [4.6](/filings/0001140361-26-039951.md) | [32.4](/filings/0001140361-26-039951.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/aame/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $553.5k | 331,411 | | Unchanged | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $268.4k | 160,716 | | Reduced −8,391 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $179.4k | 107,440 | | Reduced −141 | | [BIGLARI, SARDAR](/funds/1334430.md) | 2026-06-30 | $176.8k | 105,861 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $101.6k | 60,825 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $86.5k | 51,800 | | Added +4,900 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $73.5k | 44,000 | | Added +8,595 | | [Foster Victor Wealth Advisors, LLC](/funds/1769063.md) | 2026-06-30 | $71.7k | 44,000 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $46.3k | 27,716 | | Unchanged | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $44.3k | 26,531 | | Added +235 | ## Recent filings [All 376 filings](/companies/aame/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 18:30 ET | [DEF 14A](/filings/0001140361-26-040638.md) | Proxy statement, period 2026-11-10 | 0001140361-26-040638 | | 2026-10-22 | 21:03 ET | [8-K](/filings/0001140361-26-040528.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001140361-26-040528 | | 2026-10-19 | 01:54 ET | [10-K/A](/filings/0001140361-26-039951.md) | Annual report, amended, period 2025-12-31 | 0001140361-26-039951 | | 2026-10-16 | 20:42 ET | [10-K](/filings/0001140361-26-039933.md) | Annual report, period 2025-12-31 | 0001140361-26-039933 | | 2026-10-16 | 19:37 ET | [8-K](/filings/0001140361-26-039912.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-039912 | | 2026-08-26 | 21:03 ET | [8-K](/filings/0001140361-26-034470.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001140361-26-034470 | | 2026-08-05 | 20:20 ET | [8-K](/filings/0001140361-26-031431.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-031431 | | 2026-07-15 | 20:22 ET | [8-K](/filings/0001140361-26-028548.md) | 8.01 Other events | 0001140361-26-028548 | | 2026-06-02 | 20:32 ET | [8-K](/filings/0001140361-26-023724.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-023724 | | 2026-05-22 | 21:01 ET | [8-K](/filings/0001140361-26-022626.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001140361-26-022626 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001140361-26-039933.md), filed Oct 16, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 8177 - Tickers: AAME - Exchange: Nasdaq - SIC code: 6311 Life Insurance - State of incorporation: GA - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.